scispace - formally typeset
L

Luciano Quaranta

Researcher at University of Pavia

Publications -  127
Citations -  2969

Luciano Quaranta is an academic researcher from University of Pavia. The author has contributed to research in topics: Intraocular pressure & Glaucoma. The author has an hindex of 27, co-authored 121 publications receiving 2332 citations. Previous affiliations of Luciano Quaranta include University of Rome Tor Vergata & University of Brescia.

Papers
More filters
Journal ArticleDOI

Efficacy and Safety of Trabeculectomy vs Nonpenetrating Surgical Procedures: A Systematic Review and Meta-analysis

TL;DR: Trabeculectomy seems to be the most effective surgical procedure for reducing IOP in patients with open-angle glaucoma, however, as expected, it was associated with a higher incidence of complications when compared with NPS.
Journal ArticleDOI

Quality of Life in Glaucoma: A Review of the Literature

TL;DR: A better understanding of patient-reported QoL can improve patient–physician interaction and enhance treatment adherence by customizing treatment options based on individual patient profile, thus optimizing long-term prognosis.
Journal ArticleDOI

Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.

TL;DR: Ginkgo biloba extract administration appears to improve preexisting visual field damage in some patients with NTG, and no significant changes were found in intraocular pressure, blood pressure, or heart rate after placebo or GBE treatment.
Journal ArticleDOI

24-hour intraocular pressure and ocular perfusion pressure in glaucoma

TL;DR: A significant body of literature suggests that OPP assessment may be clinically relevant in a significant number of glaucoma patients and may provide an important tool towards a better understanding of long- and short-term IOP fluctuations during a patient's daily routine.
Journal ArticleDOI

Effects of Topical Hypotensive Drugs on Circadian IOP, Blood Pressure, and Calculated Diastolic Ocular Perfusion Pressure in Patients with Glaucoma

TL;DR: In this study of patients with newly diagnosed primary open-angle glaucoma, only dorzolamide and latanoprost significantly increased mean 24-hour DOPP, although timolol was as effective as latano during the daytime, and dorZolamide are as effective at night.